ise-view-Article Detail Bottom List


Source:Medtronic International Ltd

Date Published:12/19/2012 01:12:22 PM

Medtronic’s Arctic Front Advance? cardiac cryoballoon has received both US FDA and CE Mark approvals. The Arctic Front Advance is indicated for use in treating paroxysmal atrial fibrillation (PAF), and is an improvement on the previous Arctic Front model. The device features the new EvenCool? Cryo Technology, which optimises the delivery of coolant inside the balloon. This causes a larger, more uniform cold surface that reduces the effort needed to isolate the pulmonary veins, the target of most AF ablation procedures.

Womens Bandeau


Not interesting to Very interesting
Enter the characters shown in the image.

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.